NCT00025584
- Conditions
- Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Recurrent Breast Cancer
Explore clinical trials studying Recurrent Breast Cancer. Study availability and eligibility vary by location and protocol.
99 public trials
5 recruiting studies
Recurrent Breast Cancer trial results
NCT00045188
- Conditions
- Breast Diseases, Breast Neoplasms, Breast Neoplasms, Male, +7 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT00017394
- Conditions
- Breast Diseases, Breast Neoplasms, Breast Neoplasms, Male, +7 more
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
NCT00030498
- Conditions
- Adenocarcinoma, Adenoma, Adnexal Diseases, +185 more
- Locations
-
- Cancer and Leukemia Group B Chicago, Illinois, United States
NCT00307229
- Conditions
- Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +5 more
- Locations
-
- Sir Mortimer B. Davis - Jewish General Hospital Montreal, Quebec, Canada
Active, Not Recruiting
Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery
NCT01953588
- Conditions
- Adenocarcinoma, Breast Diseases, Breast Neoplasms, +20 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center Anchorage, Alaska, United States
Active, Not Recruiting
Copper Cu 64-DOTA-Trastuzumab PET in Predicting Response to Treatment With Ado-Trastuzumab Emtansine in Patients With Metastatic HER2 Positive Breast Cancer
NCT02226276
- Conditions
- Bone Metastases, Breast Diseases, Breast Neoplasms, +10 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
Active, Not Recruiting
A Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS)
NCT01824836
- Conditions
- Breast Diseases, Breast Neoplasms, Estrogen Receptor-positive Breast Cancer, +13 more
- Locations
-
- Eastern Cooperative Oncology Group Boston, Massachusetts, United States
- Veterans Adminstration New Jersey Health Care System East Orange, New Jersey, United States
Active, Not Recruiting
BYL719 and Letrozole in Post-Menopausal Patients With Hormone Receptor-Positive Metastatic Breast Cancer
NCT01791478
- Conditions
- Adenocarcinoma, Breast Diseases, Breast Neoplasms, +16 more
- Locations
-
- Massachusetts General Hospital, Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States